During the past decade, Carpe Diem Centrum Medycyny Estetycznej conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Carpe Diem Centrum Medycyny Estetycznej" are "Dermatitis, Atopic" (2 trials), "Plaque Psoriasis" (2 trials), "Skin Diseases" (2 trials), "Atopic Dermatitis" (1 trials) and "Dermatitis" (1 trials). Many other conditions were trialed in "Carpe Diem Centrum Medycyny Estetycznej" in a lesser frequency.

Most popular intervention types in "Carpe Diem Centrum Medycyny Estetycznej" are "Drug" (5 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abrocitinib 200 mg" (2 trials), "ABP 501" (1 trials), "Abrocitinib 100 mg" (1 trials), "Adalimumab" (1 trials) and "Dupilumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Carpe Diem Centrum Medycyny Estetycznej" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Carpe Diem Centrum Medycyny Estetycznej". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Carpe Diem Centrum Medycyny Estetycznej, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Carpe Diem Centrum Medycyny Estetycznej, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".